Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Crossref logo

Fol. Biol. 2005, 51, 109-113

https://doi.org/10.14712/fb2005051040109

Immunogenicity and Protective Effect of a DNA Construct Encoding Certain Neutralizing Epitopes of Herpes Simplex Virus Type-1 Glycoprotein B

Taravat Bamdad1, M. H. Roostaee1, M. Sadeghizadeh2, F. Mahboudi3, A. Kazemnejad4, H. Soleimanjahi1

1Department of Virology, School of Medical Sciences, Tarbiat Modarres University, Tehran, Iran
2Department of Genetics, School of Basic Sciences, Tarbiat Modarres University, Tehran, Iran
3Department of Biotechnology, Pasteur Institute, Tehran, Iran
4Department of Biostatistics, School of Medical Sciences, Tarbiat Modarres University, Tehran, Iran

Received April 2005
Accepted June 2005

References

1. An, L., Rodriguez, F., Harkins, S., Zhang, I., Whitton, J. L. (2000) Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine. Vaccine 18, 2132-2141. <https://doi.org/10.1016/S0264-410X(99)00546-0>
2. Baghian, A., Chouljenko, V. N., Dauvergne, O., Newman, M. J., Baghian, S., Kousovias, K. G. (2002) Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunization with herpes simplex virus type 1 genes specifying glycoproteins gB and gD. J. Med. Microbiol. 51, 350-357. <https://doi.org/10.1099/0022-1317-51-4-350>
3. Bernstein, D., Stanbery, L. (1999) Herpes simplex virus vaccines. Vaccine 17, 1681-1689. <https://doi.org/10.1016/S0264-410X(98)00434-4>
4. Del Val, M., Schlicht, H., Ruppert, T., Reddehase, M. J., Koszinowski, U. H. (1991) Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66, 1145-1153. <https://doi.org/10.1016/0092-8674(91)90037-Y>
5. Gaselli, E., Balboni, P. G., Incorvaia, C., Arnani, R., Parmeggiani, F., Cassai, E. (2001) Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection. Vaccine 19, 1225-1231.
6. Ghiasi, H., Kaiwer, R., Nesburn, A., Wechsler, S. L. (1999) Expression of herpes simplex virus glycoprotein B in insect cells. Virus Res. 22, 23-39.
7. Glorioso, J., Schroder, C. H., Kumel, G., Szczesiul, M., Levine, M. (1984) Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity. J. Virol. 50, 805-812. <https://doi.org/10.1128/jvi.50.3.805-812.1984>
8. Hanke, T., Graham, F., Rosenthal, K. L., Johnson, D. C. (1991) Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vector and synthetic peptides. J. Virol. 65, 1177-1186. <https://doi.org/10.1128/jvi.65.3.1177-1186.1991>
9. Higgins, T. J., Herold, K. M., Arnold, R. L., McElhiney, S. P., Shroff, K. E., Pachuk, C. J. (2000) Plasmid DNA-expressing secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses. J. Infect. Dis. 182, 1311-20. <https://doi.org/10.1086/315879>
10. Highlander, S., Cai, W., Person, S., Levine, M., Glorioso, J. C. (1991) Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration. J. Virol. 184, 253-264.
11. Hwang, Y., Spruance, S. (1999) The epidemiology of uncommon herpes simplex virus type 1 infections. Herpes 6, 16-19.
12. Manickan, E., Rouse, R., Zhiya, Y., Wire, W. S., Rouse, B. T. (1995) Genetic immunization against herpes simplex virus. J. Immunol. 155, 259-265. <https://doi.org/10.4049/jimmunol.155.1.259>
13. McClements, W. L., Armstong, M. E., Keys, R. D., Liu, M. A., (1996) Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl. Acad. Sci. USA 93, 11414-11420. <https://doi.org/10.1073/pnas.93.21.11414>
14. Mester, J. C., Twomey, T. A., Tepe, E. T., Bernstein. D. I. (2000) Immunity induced by DNA immunization with herpes simplex virus type 2 glycoprotein B and C. Vaccine 18, 875-883. <https://doi.org/10.1016/S0264-410X(99)00325-4>
15. Mikloska, Z., Sanna, P. P., Cunningham, A. L. (1999) Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro. J. Virol. 73, 5934-5944. <https://doi.org/10.1128/JVI.73.7.5934-5944.1999>
16. Navarro, D., Quadri, I., Pereira, L. (1991) A mutation in the ectodomain of herpes simplex virus 1 glycoprotein B causes defective processing and retention in the endoplasmic reticulum. Virology 184, 253-264. <https://doi.org/10.1016/0042-6822(91)90842-Y>
17. Navarro, D., Paz, P., Pereira, L. (1992) Domains of herpes simplex virus 1 glycoprotein B that function in virus penetration, cell to cell spread and cell fusion. Virology 186, 99-112. <https://doi.org/10.1016/0042-6822(92)90064-V>
18. Pereira, P., Ali, M., Kousoulas, K., Bin, H., Banks, T. (1989) Domain structure of herpes simplex virus type 1 glycoprotein B: neutralizing epitopes map in regions of continuous and discontinuous residues. Virology 178, 11-24. <https://doi.org/10.1016/0042-6822(89)90102-5>
19. Qadri, I., Gimeno, C., Navarro, D., Pereira, L. (1999) Mutations in conformation-dependent domain of herpes simplex virus type 1 glycoprotein B affect the antigenic properties, dimerization, and transport of the molecule. Virology 180, 135-152. <https://doi.org/10.1016/0042-6822(91)90017-6>
20. Rodrigues, F., An, L., Harkins, S., Zhang, J., Yokoyama, M., Widera, G. (1998) DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J. Virol. 72, 5147-5181.
21. Roizman, B., Knipe, D. M. (2001) Herpes simplex viruses and their replication. In: Fields Virology, eds. Knipe, D. M., Howley, P. M., pp. 2391-2510, Lippincott Williams & Wilkins, Philadelphia.
22. Sanchez-Pescador, L., Paz, P., Navarro, D., Pereira, L., Kohl, S. (1992) Epitopes of herpes simplex virus glycoprotein B that bind type-common neutralizing antibodies elicit typespecific antibody-dependent cellular cytotoxicity. J. Infect. Dis. 166, 623-627. <https://doi.org/10.1093/infdis/166.3.623>
23. Stanberry, L. R. (1996) Herpes immunization ñ on the threshold. J. Eur. Acad. Dermatol. Venereol. 7, 120-128.
24. Stanberry, L. R., Cunningham, A. L., Mindel, A., Scott, L. L., Spruance, S. L., Aok, F. Y., et al. (2000) Prospects for control of herpes simplex virus disease through immunization. Clin. Infect. Dis. 30, 549-566. <https://doi.org/10.1086/313687>
25. Wallace, M., Keating, R., Health, W., Carbone, F. R. (1999) The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J. Virol. 73, 7619-7626. <https://doi.org/10.1128/JVI.73.9.7619-7626.1999>
26. Yu, Z., Karem, K. L., Kanangat, S., Manickan, E., Rouse, B. T. (1998) Protection by minigenes: a novel approach of DNA vaccines. Vaccine 16, 1660-1667.
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive